These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25631643)

  • 1. [Systematic screening of masked hypertension in patients with peripheral arterial disease: a pilot study].
    Claisse G; Maldonado P; Kpogbemabou N; Boudghène-Stambouli F; Delsart P; Devos P; Mounier-Vehier C
    J Mal Vasc; 2015 Feb; 40(1):10-7. PubMed ID: 25631643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
    Naser N; Dzubur A; Durak A; Kulic M; Naser N
    Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of masked hypertension among treated hypertensive patients: an interesting association with orthostatic hypertension.
    Barochiner J; Cuffaro PE; Aparicio LS; Alfie J; Rada MA; Morales MS; Galarza CR; Waisman GD
    Am J Hypertens; 2013 Jul; 26(7):872-8. PubMed ID: 23482377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Masked arterial hypertension in patients with type2 diabetes mellitus: Prevalence, associated factors and cardiovascular impact].
    Hadjkacem F; Triki F; Frikha H; Charfeddine S; Boujelbene K; Ghorbel D; Kammoun S; Abid M
    Ann Cardiol Angeiol (Paris); 2022 Jun; 71(3):136-140. PubMed ID: 35039143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of masked hypertension in the general population: the Finn-Home study.
    Hänninen MR; Niiranen TJ; Puukka PJ; Mattila AK; Jula AM
    J Hypertens; 2011 Oct; 29(10):1880-8. PubMed ID: 21841499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of masked hypertension in hypertensive patients treated in a primary care setting.
    Andalib A; Akhtari S; Rigal R; Curnew G; Leclerc JM; Vaillancourt M; Tardif JC
    Intern Med J; 2012 Mar; 42(3):260-6. PubMed ID: 21118414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and distinguishing features of masked hypertension in type 2 diabetic patients.
    Zhou J; Liu C; Shan P; Zhou Y; Xu E; Ji Y
    J Diabetes Complications; 2013; 27(1):82-6. PubMed ID: 22906551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hypertension is "unmasked" by low-intensity exercise blood pressure.
    Schultz MG; Hare JL; Marwick TH; Stowasser M; Sharman JE
    Blood Press; 2011 Oct; 20(5):284-9. PubMed ID: 21449705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Associated factors and sub-clinical myocardial dysfunction in obese patients with masked hypertension].
    Charfeddine S; Hadj Kacem F; Bahloul A; Triki F; Hammami R; Rebai M; Abid M; Abid L; Kammoun S
    Ann Cardiol Angeiol (Paris); 2022 Feb; 71(1):6-10. PubMed ID: 34140143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Masked hypertension in renal transplant recipients.
    Kayrak M; Gul EE; Kaya C; Solak Y; Turkmen K; Yazici R; Guney I; Altintepe L; Turk S; Ozdemir K
    Blood Press; 2014 Feb; 23(1):47-53. PubMed ID: 23721572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambulatory blood pressure monitoring in diabetic hypertensive patients, single center report--preliminary results.
    Josipović J; Marinac D; Katicić D; Detelić D; Pavlović D
    Coll Antropol; 2013 Sep; 37(3):795-800. PubMed ID: 24308219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of office blood pressure and their operating characteristics for detecting masked hypertension based on ambulatory blood pressure monitoring.
    Viera AJ; Lin FC; Tuttle LA; Shimbo D; Diaz KM; Olsson E; Stankevitz K; Hinderliter AL
    Am J Hypertens; 2015 Jan; 28(1):42-9. PubMed ID: 24898379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-time blood pressure and the prognostic value of isolated-office and masked hypertension.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Am J Hypertens; 2012 Mar; 25(3):297-305. PubMed ID: 22089106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we screen for masked hypertension in patient with vascular disease?
    Delsart P; Marboeuf P; Delhaye C; Lemesle G; Mounier-Vehier C
    Vasc Health Risk Manag; 2010 May; 6():333-8. PubMed ID: 20531952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident Left Ventricular Hypertrophy in Masked Hypertension.
    Cuspidi C; Facchetti R; Quarti-Trevano F; Sala C; Tadic M; Grassi G; Mancia G
    Hypertension; 2019 Jul; 74(1):56-62. PubMed ID: 31104565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and characteristics of isolated nocturnal hypertension in the general population.
    Rhee MY; Kim JS; Kim CH; Kim JH; Lee JH; Kim SW; Nah DY; Gu N; Cho EJ; Sung KC; Hong KS
    Korean J Intern Med; 2021 Sep; 36(5):1126-1133. PubMed ID: 34503319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The validity of a daytime ambulatory blood pressure to diagnose masked hypertension.
    Kinsara AJ; Elshiekh AH; Abuosa AM; Galzerano D; Abrar MB
    Monaldi Arch Chest Dis; 2020 Jul; 90(3):. PubMed ID: 32724229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function.
    Marchesi C; Maresca AM; Solbiati F; Franzetti I; Laurita E; Nicolini E; Gianni M; Guasti L; Marnini P; Venco A; Grandi AM
    Am J Hypertens; 2007 Oct; 20(10):1079-84. PubMed ID: 17903691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for masked hypertension within a population of controlled hypertensives.
    Mallion JM; Clerson P; Bobrie G; Genes N; Vaisse B; Chatellier G
    J Hypertens; 2006 Dec; 24(12):2365-70. PubMed ID: 17082717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.